HomeStock ScreenerMedi CapsFinancial Statements

Medi Caps Complete Financial Statements

11 Years of Data
2025 - 2015

In FY2025, Medi Caps (MEDICAPQ) reported revenue ₹4 Cr, net profit ₹-2 Cr and EPS ₹-1.46, with a net profit margin of -50.0% and ROE of -1.7%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Medi Caps stock price NSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -50.00% 2025 data
EBITDA Margin -25.00% 2025 data
Operating Margin -145.00% 2025 data
Return on Assets -1.60% 2025 data
Return on Equity -1.65% 2025 data

Balance Sheet Ratios

Current Ratio 53.00 2025 data
Equity Ratio 96.80% 2025 data
Asset Turnover 0.03 2025 data

MEDICAPQ Revenue, Net Profit & EBITDA — Year-on-Year Growth

MEDICAPQ YoY (Sept 2024 vs Sept 2025) — revenue -55.6%, EBITDA -200.0%, expenses -37.5%. Review MEDICAPQ earnings multiple to evaluate earnings-based valuation against sector peers.

Revenue Growth
-55.6%
Year-over-Year
EBITDA Growth
-200.0%
Year-over-Year
Expense Growth
-37.5%
Year-over-Year
Assets Growth
-1.6%
Year-over-Year
Operating Cash Flow Growth
-28.6%
Year-over-Year
Investing Cash Flow Growth
+37.5%
Year-over-Year

MEDICAPQ Income Statement — Revenue, EBITDA & Net Profit

Medi Caps revenue ₹4 Cr, EBITDA ₹-1 Cr, net profit ₹-2 Cr, EPS ₹-1.46 (2025) — net profit margin -50.0%. Explore MEDICAPQ Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Jun 2018 Dec 2018
Revenue 4 9 3 5 9 8 6 4 6 10 6 7 16 18 13 11 17 14 17 18 15 7 12 18 12 16 16 10 16 9 12
Expenses 5 7 6 5 8 8 7 6 6 10 7 6 14 17 12 9 14 11 14 16 11 9 10 15 14 13 15 12 13 10 11
EBITDA -1 2 -3 0 1 -1 0 -2 1 1 -1 1 3 1 1 2 4 3 4 2 3 -2 2 4 -2 2 1 -3 3 -1 1
Operating Profit Margin % -145.00% -4.00% -126.00% -25.00% 5.00% -13.00% -5.00% -45.00% 8.00% 4.00% -14.00% 8.00% 11.00% -3.00% 5.00% 14.00% 20.00% 16.00% 21.00% 11.00% 23.00% -52.00% 17.00% 20.00% -4.00% 13.00% 5.00% -45.00% 18.00% -26.00% 14.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 1 1 0 0 0 0 0 1 1 1 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -2 2 -4 -1 0 -1 -1 -2 0 1 -1 0 2 2 1 1 3 3 3 2 3 -1 2 3 -2 2 1 -3 3 -2 2
Tax 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -2 2 -4 -1 0 -1 -1 -2 0 0 -1 0 2 2 1 -1 3 3 3 2 3 -1 2 3 -2 2 1 -3 3 -2 2
Earnings Per Share (₹) -1.46 1.38 -2.80 -0.61 0.25 -0.86 -0.45 -1.64 0.09 -0.31 -0.89 -0.13 1.72 1.20 0.48 -1.07 2.56 2.42 3.20 1.64 2.89 -0.90 2.33 3.45 -1.54 1.80 1.60 -2.63 2.16 -1.41 1.77

MEDICAPQ Balance Sheet — Assets, Liabilities & Shareholders' Equity

MEDICAPQ total assets ₹125 Cr, total equity ₹121 Cr, total liabilities ₹ Cr (2025) — ROE -1.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 125 127 126 130 115 95 107 101 97 93 89
Current Assets 53 60 60 67 53 33 42 37 33 32 27
Fixed Assets 57 59 59 59 58 57 60 61 62 56 58
Capital Work in Progress 0 0 0 0 1 1 0 0 0 0 0
Investments 43 38 32 31 29 22 16 11 8 3 2
Other Assets 25 30 35 40 27 15 31 29 27 34 30
LIABILITIES
Total Liabilities
Current Liabilities 1 1 1 1 1 1 2 2 2 1 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 121 121 119 116 105 91 96 90 89 82 81
Share Capital 13 13 13 13 13 13 13 13 13 13 13
Reserves & Surplus 109 109 106 104 92 79 83 78 77 70 69

MEDICAPQ Cash Flow Statement — Operating, Investing & Financing

Medi Caps operating cash flow ₹5 Cr, investing ₹-5 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 5 7 -6 7 15 5 6 4 4 3 7
Investing Activities -5 -8 -3 -4 -10 -6 -6 -4 3 -2 -7
Financing Activities 0 0 0 0 0 0 0 0 -6 -1 0
Net Cash Flow 0 -1 -9 3 6 -1 0 0 1 0 0